Non-invasive liver fibrosis tests in non-alcoholic fatty liver disease [PDF]
In the last two decades, several non-invasive liver fibrosis tests have been introduced in clinical practice and transformed the investigation of patients with non-alcoholic fatty liver disease.
Liguori, Antonio+2 more
core
Pathology of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of different conditions which are characterized by hepatic steatosis in the absence of secondary causes. It is currently the most common chronic liver disease worldwide, and its estimated prevalence is about 1.5-6.5%.
Cataldo, Ivana+7 more
openaire +5 more sources
Non-alcoholic fatty liver disease and diabetes [PDF]
Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2DM) are common conditions that regularly co-exist and can act synergistically to drive adverse outcomes. The presence of both NAFLD and T2DM increases the likelihood of the development of complications of diabetes (including both macro- and micro- vascular complications) as well as ...
Hazlehurst, Jonathan M.+4 more
openaire +3 more sources
Arterial hypertension, obesity and non-alcoholic fatty liver disease: is there any connection? [PDF]
The combination of hypertension, obesity and non-alcoholic fatty liver disease occurs in medical practice very often. A number of studies have shown that non-alcoholic fatty liver disease increases the risk of cardiovascular disease independently of ...
Gribenyuk, Olena Viktorivna+3 more
core +2 more sources
Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome [PDF]
There is evidence from animal and in-vitro studies that activation of the endocannabinoid system (EC) through cannabinoid receptor 1 (CB-1) is associated with liver injury, inflammation and hepatocellular carcinoma.1 Data suggests endogenous cannabinoids
Ahmed, Lina+6 more
core +1 more source
A sweet connection? Fructose’s role in hepatocellular carcinoma [PDF]
Hepatocellular carcinoma is one of few cancer types that continues to grow in incidence and mortality worldwide. With the alarming increase in diabetes and obesity rates, the higher rates of hepatocellular carcinoma are a result of underlying non ...
Dewdney, Brittany+4 more
core +1 more source
Pediatric Non-Alcoholic Fatty Liver Disease [PDF]
Abstract: With the increase in the prevalence of obesity, non-alcoholic fatty liver disease (NAFLD) has become among the leading causes of chronic liver disease in the pediatric age group. Once believed to be a “two-hit process”, it is now clear that the actual pathophysiology of NAFLD is complex and involves multiple pathways.
Zobair M. Younossi+3 more
openaire +3 more sources
Oxidative stress: new insights on the association of nonalcoholic fatty liver disease and atherosclerosis [PDF]
Non-alcoholic fatty liver disease (NAFLD) represents the most common and emerging chronic liver disease worldwide. It includes a wide spectrum of liver diseases ranging from simple fatty liver to non-alcoholic steatohepatitis (NASH), which may progress ...
Albanese, Fabiana+7 more
core +1 more source
Treatment of Non-Alcoholic Fatty Liver Disease [PDF]
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of conditions from steatosis to cirrhosis and hepatocellular carcinoma. Steatosis is a benign reversible condition, which does not need treatment. Cirrhosis and hepatocellular carcinoma are the end stages of any chronic liver disease and do not have etiology-specific treatments.
Scherer, Antonia, Dufour, Jean-François
openaire +3 more sources
The use of ultrasound in clinical setting for children affected by NAFLD. is it safe and accurate? [PDF]
Non-alcoholic fatty liver disease (NAFLD) has become over the last decade the most common form of chronic liver disease in children and adults. Thus, establishing the diagnosis of NAFLD is of utmost importance and represents a major challenge as the ...
Alisi A+4 more
core +3 more sources